Evaluating Payment to Participate in Research: Ethical and Regulatory Issues
In this webinar, Luke Gelinas, IRB Chairperson at Advarra, proposes a practical framework for evaluating offers of payment and applies it to case studies to yield guidance on challenging ethical and regulatory issues involved in paying research subjects.
How Medicare’s New Imaging Program Affects Clinical Trials in Oncology
Billing compliance is an essential part of clinical trial participation, and this is especially important for high-cost services such as CT scans, PET scans, nuclear medicine, and MRIs. However, organizations ...
Addressing Key COVID-19 Challenges Through Enterprise Technology
Throughout the COVID-19 pandemic, research institutions have addressed a wide array of challenges to keep research moving. As we look forward, many institutions still have unanswered questions on how to ...
Research Staffing Strategies During Challenging Times
With hiring freezes, furloughs, in-person restrictions, and changes in workflows and documentation, the COVID-19 pandemic has had a significant effect on clinical research staffing. What will it look like when ...
Racial Diversity in Clinical Trials: Building Trust in Participant Engagement
COVID-19 has focused the importance of diversity, equity, and inclusion considerations in clinical trial enrollment. How can the research community address the root causes for lack of diversity? What actions ...
Study Startup Success for the New Generation of Genetically Engineered Vaccines
The global COVID-19 pandemic has brought vaccine research to the forefront, and a surge of research involving genetically engineered vaccines is currently taking place. The availability of the viral genome ...
The Must-Haves of FDA and Common Rule Reporting Requirements
The Food and Drug Administration (FDA) regulations governing Investigational New Drug (IND) applications contain specific reporting requirements. Similarly, the Common Rule (i.e., the federal policy for the protection of human ...
Build a Better Budget: Using Medicare Coverage Analysis to Streamline Study Startup
Need to improve your study startup timelines? Consider adding a Medicare Coverage Analysis (MCA) to your toolkit. By leveraging an MCA when building your clinical trial budget template, you can ...
The New Urgency of Clinical Trials: How Oncology Leads the Evolution
Join colleagues from the research community for a discussion on the evolution of clinical trials and how oncology research has influenced agility in clinical trial design.
From Reactive to Proactive: How to Evolve Your Research Program During a Global Crisis
Many research programs are evaluating how to keep research moving forward in the face of critical staff shortages and budget limitations—during the COVID-19 pandemic and beyond. Sites are busier than ...
Institutional Perspectives: Leveraging Technology to Meet Operational Goals During COVID-19
The COVID-19 pandemic ushered in a myriad of changes for clinical research professionals. One of the most impactful has been the immediate shift to remote processes to accommodate both research ...
Fireside Chat: The Future of Clinical Trials and Site Engagement
The COVID-19 pandemic has proven that research can be done more efficiently. To make these efficiencies sustainable, the sites’ perspective must be considered. Sponsors, CROs, and sites should engage early ...